Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors can now capture rewards from the protocol commanding over 50% of DEX perpetual open interest Zurich, 21 April 2026 – 21shares, a global leader in cryptocurrency exchange-traded products...
-
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If...
-
SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN Sika stärkt die Position in Zentralasien mit der Gründung einer neuen Ländergesellschaft in Kirgisistan. Mit...
-
SIKA EXPANDS ITS ACTIVITIES IN CENTRAL ASIA WITH A NEW NATIONAL SUBSIDIARY IN KYRGYZSTAN Sika is strengthening its position in Central Asia by establishing a new national subsidiary in Kyrgyzstan....
-
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 21, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...
-
MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic...
-
Allschwil, 15. April 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
-
Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
-
Generalversammlung 2026: Aktionäre stimmen sämtlichen Anträgen des Verwaltungsrats zu, darunter eine gleichbleibende Dividende von CHF 3.00 pro Aktie Männedorf, Schweiz, 15. April 2026 – Die...
-
Annual General Meeting 2026: Tecan shareholders endorse all motions proposed by the Board of Director including stable dividend of CHF 3.00 per share Männedorf, Switzerland, April 15, 2026 – The...